2024 annual financial data
Arbutus Biopharma 2024 Operating margin
Direct answer
Operating margin was -1,236.74%.
Operating income was -76,319,000 USD and net income was -69,920,000 USD.
Operating cash flow was -64,850,000 USD.
Get free Arbutus Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 6,171,000 USD
- Operating income
- -76,319,000 USD
- Net income
- -69,920,000 USD
- Operating cash flow
- -64,850,000 USD